Alliqua BioMedical, Inc. is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds. Alliqua is building this portfolio through its proprietary hydrogel technology platform, targeted acquisitions, and through licensing and distribution agreements with strategic partners that include sorbion GmbH & Co. KG and Celgene Cellular Therapeutics, a subsidiary of Celgene Corporation. Alliqua's contract manufacturing business unit provides custom hydrogels to the OEM market. The Company is headquartered in Langhorne, PA.
Company Growth (employees)
Type
Public
HQ
Morrisville, US
Size (employees)
81 (est)-6%
Alliqua is headquartered in Morrisville, US

Key People at Alliqua

David Johnson

David Johnson

CEO, and Member of the Board of Directors
Brad C. Barton

Brad C. Barton

COO
Phillip Forman

Phillip Forman

Executive VP Clinical Affairs

Alliqua Office Locations

Alliqua has an office in Morrisville
Morrisville, US (HQ)
200 1010 Stony Hill Rd

Alliqua Data and Metrics

Alliqua Financial Metrics

Alliqua's revenue was reported to be $18.2 m in FY, 2016
USD

Net income (Q1, 2017)

(7 m)

EBIT (Q1, 2017)

(5.8 m)

Market capitalization (21-Sep-2017)

19 m

Cash (31-Mar-2017)

2.4 m
Alliqua's current market capitalization is $19 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.8 m4.8 m15 m18.2 m

Revenue growth, %

166%214%21%

Cost of goods sold

2.1 m3.3 m6 m6.7 m

Gross profit

(299.3 k)1.5 m9 m11.6 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cost of goods sold

836.7 k915.8 k1.2 m1.4 m1.7 m1.8 m1.6 m1.8 m1.7 m

General and administrative expense

10.1 m9.6 m8.9 m7.7 m

Operating expense total

10.1 m9.6 m8.9 m7.7 m

EBIT

(6.2 m)(5.2 m)(7.7 m)(8.1 m)(7.8 m)(7.8 m)2.1 m(7.8 m)(5.8 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

12.1 m16.8 m26.1 m5.6 m

Accounts Receivable

156.8 k968.6 k2.5 m2.8 m

Inventories

88.4 k477.8 k942 k2.7 m

Current Assets

12.8 m19.6 m32.7 m11.8 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

23.8 m19.9 m10.9 m35.8 m30.7 m17 m12.6 m10.7 m2.4 m

Accounts Receivable

474.4 k715.6 k1.4 m2.3 m2.4 m2.5 m2.5 m2.7 m2.9 m

Inventories

940.7 k1.1 m1.6 m2.9 m3.5 m3.5 m3.1 m3.2 m2.6 m

Current Assets

25.3 m22 m14.8 m41.7 m37.5 m24.1 m23.5 m17.6 m8.3 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(22 m)(25.4 m)(26 m)(28.2 m)

Depreciation and Amortization

674.2 k2.9 m4.2 m

Accounts Receivable

(48 k)968.6 k(779.5 k)(281 k)

Inventories

105.3 k477.8 k(257.3 k)(113 k)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(6 m)(5.1 m)(7.7 m)(7 m)(7.1 m)(7.7 m)5.2 m(8.6 m)(7 m)

Accounts Receivable

474.4 k715.6 k1.4 m2.3 m2.4 m2.5 m2.5 m2.7 m2.9 m

Accounts Payable

1.6 m1.1 m1.8 m2.4 m2.8 m2.4 m2.1 m2.6 m2.3 m
Y, 2017

Financial Leverage

1.7 x
Show all financial metrics

Alliqua Market Value History

Traffic Overview of Alliqua

Alliqua Online and Social Media Presence

Alliqua News and Updates

BRIEF-Alliqua Biomedical sees 2016 revenue $20 mln to $22 mln

* Alliqua Biomedical Inc and BSN Medical Inc announce definitive agreement on distribution rights for Sorbion dressing products in the U.S., Canada and Latin America; Alliqua updates fiscal year 2016 outlook

BRIEF-Alliqua Biomedical sees Q2 revenue about $5.4 mln

* Alliqua biomedical, inc. Announces preliminary second quarter of fiscal year 2016 revenue; earnings conference call scheduled for august 9th

Alliqua Company Life and Culture

You may also be interested in